In recent years, the study of psychedelic science has resurfaced as scientists and therapists
are again exploring its potential to treat an array of psychiatric conditions, such as …

Introduction Interest in the use of psychedelic substances for the treatment of mental
disorders is increasing. Processes that may affect therapeutic change are not yet fully …

Monoterpenoid indole alkaloids (MIAs) represent a large class of plant natural products with
marketed pharmaceutical activities against a wide range of indications, including cancer …

Mental disorders are rising while development of novel psychiatric medications is declining.
This stall in innovation has also been linked with intense debates on the current diagnostics …

Traumatic brain injury (TBI) is a leading cause of disability. Sequelae can include functional
impairments and psychiatric syndromes such as post-traumatic stress disorder (PTSD) …

The treatment of opioid withdrawal is an important area of clinical concern when treating
patients with chronic, non-cancer pain, patients with active opioid use disorder, and patients …

Research on psychedelics has seen a recent revival, with many clinical trials focused on
their therapeutic potential to treat a range of mental health conditions. The purpose of this …

The need to identify effective therapies for the treatment of psychiatric disorders is a
particularly important issue in modern societies. In addition, difficulties in finding new drugs …

Background and aims Despite promising findings indicating the therapeutic potential of
psychedelic experience across a variety of domains, the mechanisms and factors affecting …

Abstract Lower Urinary Tract Symptoms (LUTS) are frequently present in the general
population as patients age with approximately a third of individuals experiencing LUTS …